Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions

Anesthesiology

Volumn 103, Issue 5, 2005, Pages 969-977

  Dahmani, Souhayl ^a   Rouelle, Danielle ^b   Gressens, Pierre ^b   Mantz, Jean ^a  

^a BEAUJON HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 8 BROMO CYCLIC MONOPHOSPHATE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BISINDOLYLMALEIMIDE; CASPASE 3; CHELERYTHRINE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DEXMEDETOMIDINE; FOCAL ADHESION KINASE; ISOBUTYLMETHYLXANTHINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATE; PHOSPHODIESTERASE INHIBITOR; PRAZOSIN; PROPIDIUM IODIDE; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; YOHIMBINE;

ANALGESIA; ANIMAL TISSUE; ANOXIA; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; FLUORESCENCE; HYPOGLYCEMIA; HYPOXIA; IMMUNOBLOTTING; IMMUNOREACTIVITY; ISCHEMIA; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION; SEDATION; STEREOCHEMISTRY;

EID: 27644530423     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200511000-00011     Document Type: Article

References (36)

1. Fraser CM, Arakawa S, McCombie WR, Venter JC: Cloning, sequence analysis, and permanent expression of a human alpha 2-adrenergic receptor in Chinese hamster ovary cells: Evidence for independent pathways of receptor coupling to adenylate cyclase attenuation and activation. J Biol Chem 1989; 264:11754-61
2. 2-adrenergic agonists. ANESTHESIOLOGY 2000; 93:1345-9
3. Martin E, Ramsay G, Mantz J, Sum-Ping ST: The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 2003; 18:29-41
4. Ramsay MA, Luterman DL: Dexmedetomidine as a total intravenous anesthetic agent. ANESTHESIOLOGY 2004; 101:787-90
5. Lakhlani PP, MacMillan LB, Guo TZ, McCool BA, Lovinger DM, Maze M, Limbird LE: Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci U S A 1997; 94:9950-5
6. 2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. ANESTHESIOLOGY 2003; 98:428-36
7. 2-adrenergic antagonist atipamezole. ANESTHESIOLOGY 1991; 75:328-32
8. 2-adrenoceptor agonists on perinatal excitotoxic brain injury: Comparison of clonidine and dexmedetomidine. ANESTHESIOLOGY 2002; 96:134-41
9. Kim HK, Zornow MH, Strnat MA, Maze M: Dexmedetomidine does not attenuate increases in excitatory amino acids after transient global ischemia in the rabbit. J Neurosurg Anesthesiol 1996; 8:230-6
10. 2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. ANESTHESIOLOGY 2002; 96:450-7
11. Engelhard K, Werner C, Eberspacher E, Bachl M, Blobner M, Hildt E, Hutzler P, Kochs E: The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 2003; 96:524-31
12. Girault JA, Costa A, Derkinderen P, Studler JM, Toutant M: FAK and PYK2/CAKbeta in the nervous system: A link between neuronal activity, plasticity and survival? Trends Neurosci 1999; 22:257-63
13. Derkinderen P, Toutant M, Burgaya F, Le Bert M, Siciliano JC, de Franciscis V, Gelman M, Girault JA: Regulation of a neuronal form of focal adhesion kinase by anandamide. Science 1996; 273:1719-22
14. Dahmani S, Tesniere A, Rouelle D, Toutant M, Desmonts JM, Mantz J: Effects of anesthetic agents on focal adhesion kinase (pp125FAK) tyrosine phosphorylation in rat hippocampal slices. ANESTHESIOLOGY 2004; 101:344-53
15. Zhou D, Song ZH: CB1 cannabinoid receptor-mediated tyrosine phosphorylation of focal adhesion kinase-related non-kinase. FEBS Lett 2002; 525:164-8
16. National Institutes of Health: Guide for the Care and Use of Laboratory Animals. NIH Publication No. 86-23. Bethesda, National Institutes of Health, 1996, pp 58-9
17. Popovic R. Liniger R, Bidder PE: Anesthetics and mild hypothermia similarly prevent hippocampal neuron death in an in vitro model of cerebral ischemia. ANESTHESIOLOGY 2000; 92:1343-9
18. Yuan HB, Huang Y, Zheng S, Zuo Z: Hypothermic preconditioning increases survival of Purkinje neurons in rat cerebellar slices after an in vitro simulated ischemia. ANESTHESIOLOGY 2004; 100:331-7
19. Laake JH, Haug FM, Wieloch T, Ottersen OP: A simple in vitro model of ischemia based on hippocampal slice cultures and propidium iodide fluorescence. Brain Res Brain Res Protoc 1999; 4:173-84
20. Noraberg J, Kristensen BW, Zimmer J: Markers for neuronal degeneration in organotypic slice cultures. Brain Res Brain Res Protoc 1999; 3:278-90
21. Derkinderen P, Siciliano J, Toutant M, Girault JA: Differential regulation of FAK+ and PYK2/Cakbeta, two related tyrosine kinases, in rat hippocampal slices: Effects of LPA, carbachol, depolarization and hyperosmolarity. Eur J Neurosci 1998; 10:1667-75
22. Derkinderen P, Toutant M, Kadare G, Ledent C, Parmentier M, Girault JA: Dual role of Fyn in the regulation of FAK+6,7 by cannabinoids in hippocampus. J Biol Chem 2001; 276:38289-96
23. Yu DH, Qu CK, Henegariu O, Lu X, Feng GS: Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J Biol Chem 1998; 273:21125-31
24. Manes S, Mira E, Gomez-Mouton C, Zhao ZJ, Lacalle RA Martinez-AC: Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol Cell Biol 1999; 19:3125-35
25. Segal IS, Vickery RG, Walton JK, Doze VA, Maze M: Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor. ANESTHESIOLOGY 1988; 69:818-23
26. Tonner PH, Scholz J, Koch C, Schulte am Esch J: The anesthetic effect of dexmedetomidine does not adhere to the Meyer-Overton rule but is reversed by hydrostatic pressure. Anesth Analg 1997; 84:618-22
27. 125 FAK) content induced by oxygen glucose deprivation. Br J Anaesth 2004; 93:270-4
28. Larsen M, Haugstad TS, Berg-Johnsen J, Langmoen IA: The effect of isoflurane on brain amino acid release and tissue content induced by energy deprivation. J Neurosurg Anesthesiol 1998; 10:166-70
29. Kass IS, Amorim P, Chambers G, Austin D, Cottrell JE: The effect of isoflurane on biochemical changes during and electrophysiological recovery after anoxia in rat hippocampal slices. J Neurosurg Anesthesiol 1997; 9:280-6
30. JO. Horiguchi T, Shima H, Suga S, Ogino M, Shimizu K, Toya S, Nagao M, Kawase T: Transient forebrain ischemia induces expression of serine/threonine protein phosphatase 1 mRNA in the vulnerable regions of gerbil brain. Neurosci Lett 2002; 325:115-8
31. Sato Y, Laskowitz DT, Bennett ER, Newman MF, Warner DS, Grocott HP: Differential cerebral gene expression during cardiopulmonary bypass in the rat: Evidence for apoptosis? Anesth Analg 2002; 94:1389-94
32. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA: Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A 1995; 92:7162-6
33. Messina S, Onofri F, Bongiorno-Borbone L, Giovedi S, Valtorta F, Girault JA, Benfenati F: Specific interactions of neuronal focal adhesion kinase isoforms with Src kinases and amphiphysin. J Neurochem 2003; 84:253-65
34. Patel P: No magic bullet: the ephemeral nature of anesthetic-mediated neuroprotection. Anesthesiology 2004; 101:1049-51
35. Angst MS, Ramaswamy B, Davies MF, Maze M: Comparative analgesic and mental effects of increasing plasma concentrations of dexmedetomidine and alfentanil in humans. ANESTHESIOLOGY 2004; 101:744-52
36. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD: The effects of increasing plasma concentrations of dexmedetomidine in humans. ANESTHESIOLOGY 2000; 93:382-94